Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
VENABLE LLP for STRIVE SPECIALTIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
NATURAL STATE CONSULTING AND STRATEGIES for TURBARE MANUFACTURING
1st Quarter (Jan 1 - Mar 31) 2026 · Arkansas · House · Senate · $20,000.00 income
Pharmacy
View →
Q1
BALLARD PARTNERS for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · $90,000.00 income
Health Issues, Pharmacy
View →
Q1
MASSACHUSETTS MEDICAL SOCIETY for MASSACHUSETTS MEDICAL SOCIETY
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Immigration
View →
Q1
FAEGRE DRINKER BIDDLE & REATH LLP for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income
Health Issues, Pharmacy
View →
Q1
BALLARD PARTNERS for MADRIGAL PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $120,000.00 income
Pharmacy
View →
Q1
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
Q1
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate
Pharmacy
View →
Q1
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH for THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate
Budget/Appropriations, Pharmacy, Veterans, Environment/Superfund
View →
Q1
SQUIRE PATTON BOGGS for SK AMERICAS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $110,000.00 income
Environment/Superfund, Pharmacy, Science/Technology, Taxation/Internal Revenue Code
View →
Q1
COREWELL HEALTH for COREWELL HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · Michigan · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Labor Issues/Antitrust/Workplace
View →
Q1
B. BRAUN MEDICAL for B. BRAUN MEDICAL
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate
Consumer Issues/Safety/Products, Health Issues, Tariff (miscellaneous tariff bills), Pharmacy
View →
4T
LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Pharmacy, Health Issues
View →
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for CENCORA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
Q1
PRINTING UNITED ALLIANCE for PRINTING UNITED ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Advertising, Apparel/Clothing Industry/Textiles, Environment/Superfund, Labor Issues/Antitrust/Workplace
View →
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · $20,000.00 income
Pharmacy
View →
Q1
UNITE HERE! for UNITE HERE!
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate
Health Issues, Labor Issues/Antitrust/Workplace, Transportation, Immigration
View →
Q1
VENN STRATEGIES for THE PERSONAL CARE PRODUCTS COUNCIL
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income
Health Issues, Pharmacy
View →
Q1
WAKEFERN FOOD CORP. for WAKEFERN FOOD CORP.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Pharmacy, Law Enforcement/Crime/Criminal Justice, Agriculture, Financial Institutions/Investments/Securities
View →
Q1
CHECKMATE GOVERNMENT RELATIONS for GSK
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $60,000.00 income
Health Issues, Pharmacy
View →
Q1
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CHILDREN'S NATIONAL MEDICAL CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for MCKESSON CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CVS HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q1
ALB SOLUTIONS for VERTEX PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Pharmacy
View →
Previous Page 12 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem